✦ LIBER ✦

Prediction of response to infliximab in Crohn's disease

✍ Scribed by R. Chaudhary; S. Ghosh

Book ID: 119227967
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 57 KB
Volume: 37
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2005.04.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are systemic inflammatory markers useful

Are systemic inflammatory markers useful in the prediction of response to infliximab in Crohn's disease?

✍ Louis, Edouard J.; Vermeire, Severine; Rutgeerts, Paul; De Vos, Martine; Van Gos 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Sa1237 Prediction of Primary Response to

Sa1237 Prediction of Primary Response to Infliximab in Crohn's Disease: A Matrix-Based Prediction Model

✍ Billiet, Thomas; de Bruyn, Magali; Ballet, Vera; Claes, Karolien; Liu, Xinjun; K 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Predictive value of epithelial gene expr

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

✍ Ingrid Arijs; Roel Quintens; Leentje Van Lommel; Kristel Van Steen; Gert De Hert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Background: Infliximab (IFX) has become the mainstay of therapy of refractory Crohn's disease (CD). However, a subset of patients shows incomplete or no response to this agent. In this study we investigated whether we could identify a mucosal gene panel to predict (non)response to IFX in CD. Method

544 Predicting Response to Infliximab in

544 Predicting Response to Infliximab in Crohn's Disease: Role of CRP, MR Enterography and NOD2 Genotype

✍ Finlay A. Macrae; Gregor J. Brown; Paula Lewis; Bernadette Viney; Cathy Pizzey; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Smoking, age, duration of disease, gende

Smoking, age, duration of disease, gender, and other clinical factors do not predict response to infliximab in Crohn's disease patients

✍ Fefferman, David S.; Lodhavia, Parag J.; Reinert, Steven; Hani, Abdallah; Falchu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Prediction of response to treatment with

Prediction of response to treatment with infliximab (Remicade®) in a German prospective open-label multicenter trial in refractory Crohn's disease

✍ Andus, Tilo; Herfarth, Hans; Obermeier, Florian; Kuehbacher, Tanja; Mascheretti, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB